Sacral neuromodulation outcomes in the management of lower urinary tract symptoms in multiple sclerosis patients
Authors:
- Tyler TrumpTTTyler Trump
- Po-Ming ChowPCPo-Ming Chow
- Vivian HuaVHVivian Hua
- Omer AnisOAOmer Anis
- Mazen MansourMMMazen Mansour
- Howard B. GoldmanHGHoward B. Goldman
Open Access
- 10 February 2025
- journal article
- Published by Elsevier in Continence
- Vol. 13
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Sacral neuromodulation for voiding dysfunction and urinary retentionContinence, 2024
- Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of UrologyWorld Journal of Urology, 2023
- Prospective, multicenter study to evaluate performance and safety of a re‐engineered temporary lead for InterStim™ therapy evaluationNeurourology and Urodynamics, 2022
- Initial experience using the Axonics sacral neuromodulation system in patients with multiple sclerosisNeurourology and Urodynamics, 2022
- Long‐term real‐life adherence of percutaneous tibial nerve stimulation in over 400 patientsNeurourology and Urodynamics, 2019
- International Continence Society best practice statement for use of sacral neuromodulationNeurourology and Urodynamics, 2018
- Chapter 6: Practical aspects of administration of onabotulinumtoxinANeurourology and Urodynamics, 2014
- Sacral neuromodulation in patients with multiple sclerosisWorld Journal of Urology, 2011
- Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: Systematic Review and Meta-analysisEuropean Urology, 2010
- Sacral Nerve Stimulation for Treatment of Refractory Urinary Retention: Long-Term Efficacy and DurabilityUrology, 2008